| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.092 | 0.004 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.004 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.098 | 0.005 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.006 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.007 |